{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:57:27Z","timestamp":1770447447772,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.anai.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T02:33:01Z","timestamp":1481509981000},"page":"601-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Safety of intranasal corticosteroids"],"prefix":"10.1016","volume":"117","author":[{"given":"Greg W.","family":"Bensch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2016.06.009_bib1","series-title":"Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma","year":"2007"},{"issue":"suppl 3","key":"10.1016\/j.anai.2016.06.009_bib2","first-page":"283S","article-title":"Beclomethasone dipropionate aerosol in treatment of perennial and seasonal rhinitis: a review of five years' experience","volume":"4","author":"Brown","year":"1977","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.anai.2016.06.009_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/00016488209108539","article-title":"Long-term follow-up of intra-nasal beclomethasone treatment a clinical and histologic study","volume":"93","author":"Holopainen","year":"1982","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anai.2016.06.009_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6815-7-1","article-title":"Nasal septal perforation 1981-2005: changes in etiology, gender and size","volume":"7","author":"D\u00f8sen","year":"2007","journal-title":"BMC Ear Nose Throat Disord"},{"key":"10.1016\/j.anai.2016.06.009_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1081-1206(10)60373-0","article-title":"Pathophysiology and progression of nasal septal perforation","volume":"99","author":"Lanier","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1398-9995.2000.00370.x","article-title":"Inhaled and nasal corticosteroids: safety aspects","volume":"55","author":"Passalacqua","year":"2000","journal-title":"Allergy"},{"issue":"1, pt 2","key":"10.1016\/j.anai.2016.06.009_bib7","first-page":"S236","article-title":"An evaluation of the effects of\u00a0beclomethasone dipropionate aqueous nasal spray Vancenase AQ (VNS) on long-term growth in children","volume":"101","author":"Rachelefsky","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib8","first-page":"635","article-title":"Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids","volume":"82","author":"Wolthers","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.anai.2016.06.009_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1398-9995.1994.tb00807.x","article-title":"Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children","volume":"49","author":"Wolthers","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2016.06.009_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1398-9995.1997.tb01040.x","article-title":"Systemic effects of two nasally administered glucocorticosteroids","volume":"52","author":"Wihl","year":"1997","journal-title":"Allergy"},{"issue":"4, pt 1","key":"10.1016\/j.anai.2016.06.009_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0091-6749(98)70354-9","article-title":"Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity","volume":"101","author":"Wilson","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib12","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1542\/peds.105.2.e23","article-title":"Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate","volume":"105","author":"Skoner","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2016.06.009_bib13","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/j.jaci.2004.01.065","article-title":"Recommended once-daily dose of budesonide aqueous nasal spray (Rhinocort Aqua\u00ae) does not suppress growth velocity in pediatric patients with perennial allergic rhinitis","volume":"113","author":"Murphy","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib14","first-page":"407","article-title":"No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year","volume":"23","author":"Allen","year":"2002","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2016.06.009_bib15","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1542\/peds.105.2.e22","article-title":"Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray","volume":"105","author":"Schenkel","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2016.06.009_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaip.2014.04.008","article-title":"Growth velocity reduced with once-daily fluticasone furoate nasal spray in prepubescent children with perennial allergic rhinitis","volume":"2","author":"Lee","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2016.06.009_bib17","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.2014-1641","article-title":"Intranasal triamcinolone and growth velocity","volume":"135","author":"Skoner","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2016.06.009_bib18","series-title":"Guidance for Industry: Orally Inhaled and\u00a0Intranasal Corticosteroids: Evaluation of the Effects on Growth in Children","year":"2007"},{"key":"10.1016\/j.anai.2016.06.009_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0091-6749(05)80069-7","article-title":"A\u00a0dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology","volume":"86","author":"Meltzer","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1542\/peds.92.4.594","article-title":"Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis","volume":"92","author":"Grossman","year":"1993","journal-title":"Pediatrics"},{"issue":"1, pt 1","key":"10.1016\/j.anai.2016.06.009_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1542\/peds.112.1.96","article-title":"Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients","volume":"112","author":"Galant","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2016.06.009_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1081-1206(10)63615-0","article-title":"The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis","volume":"90","author":"Skoner","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib23","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0149-2918(97)80008-2","article-title":"Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children","volume":"19","author":"Brannan","year":"1997","journal-title":"Clin Ther"},{"issue":"4, pt 1","key":"10.1016\/j.anai.2016.06.009_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0091-6749(98)70275-1","article-title":"Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis","volume":"102","author":"Wilson","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib25","series-title":"Omnaris [packet insert]","year":"2006"},{"key":"10.1016\/j.anai.2016.06.009_bib26","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1016\/j.jaci.2006.12.277","article-title":"Lack of effect on hypothalamic-pituitary-adrenal (HPA) axis function by once-daily fluticasone furoate* nasal spray (FFNS) 110 mcg in children with perennial allergic rhinitis (PAR) *USAN approved name","volume":"119","author":"Tripathy","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1067\/mai.2000.106044","article-title":"Risk of cataract among users of intranasal corticosteroids","volume":"105","author":"Derby","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2016.06.009_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0161-6420(95)31039-1","article-title":"Intraocular pressure elevation associated with inhalation and nasal corticosteroids","volume":"102","author":"Opatowsky","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.anai.2016.06.009_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.1997.03540330044033","article-title":"Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma","volume":"277","author":"Garbe","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.anai.2016.06.009_bib30","series-title":"Veramyst [package insert]","year":"2007"},{"key":"10.1016\/j.anai.2016.06.009_bib31","first-page":"115","article-title":"Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function","volume":"25","author":"Sheth","year":"2004","journal-title":"Allergy Asthma Proc"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616303325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616303325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:15:59Z","timestamp":1761052559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120616303325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1081120616303325"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2016.06.009","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of intranasal corticosteroids","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}